Veradigm 

$4.8
24
+$0.05+1.05% Monday 20:37

統計

當日最高
4.89
當日最低
4.8
52週高點
6
52週低點
3
成交量
9,961
平均成交量
227,096
市值
519.67M
本益比
-
股息殖利率
-
股息
-

即將到來

股息

0%股息殖利率
Oct 8
$5.23
10年成長
不適用
5年成長
不適用
3年成長
不適用
1年成長
不適用

財報

27Feb預期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
0.05
0.14
0.22
0.31
預期EPS
0.07
實際EPS
不適用

財務

-14.7%利潤率
未盈利
2017
2018
2019
2020
2021
2022
1.18B營收
-172.92M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 MDRX 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Show more...
執行長
Ms. Tejal Vakharia J.D.
員工
2450
國家
US
ISIN
US01988P1084

上市

0 Comments

分享你的想法

FAQ

Veradigm 今天的股價是多少?
MDRX 目前價格為 $4.8 USD,過去 24 小時上漲了 +1.05%。在圖表上更密切關注 Veradigm 股價表現。
Veradigm 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Veradigm 的股票以代號 MDRX 進行交易。
Veradigm 的股價在上漲嗎?
MDRX 股票較上週下跌 -2.24%,本月上漲 +5.49%,過去一年 Veradigm 下跌 -8.57%。
Veradigm 的市值是多少?
今天 Veradigm 的市值為 519.67M
Veradigm 下一次財報日期是什麼時候?
Veradigm 將於 February 27, 2026 公布下一次財報。
Veradigm 上一季度的財報如何?
MDRX 上一季度的財報為每股 0.05 USD,預估為 0.05 USD,帶來 +0% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Veradigm 去年的營收是多少?
Veradigm 去年的營收為 1.18BUSD。
Veradigm 去年的淨利是多少?
MDRX 去年的淨收益為 -172.92MUSD。
Veradigm 會發放股息嗎?
是的,MDRX 的股息每 zh-tw 發放一次。每股最新股息為 5.23 USD。截至今日,股息殖利率(FWD)% 為 0%。
Veradigm 有多少名員工?
截至 February 03, 2026,公司共有 2,450 名員工。
Veradigm 位於哪個產業?
Veradigm從事於Health Care產業。
Veradigm 何時完成拆股?
Veradigm 最近沒有進行任何拆股。
Veradigm 的總部在哪裡?
Veradigm 的總部位於 US 的 Chicago。